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Abstract
Background: It is well established that drinking alcohol raises the risk of liver cancer (hepatocellular carcinoma).
However, it has not been sufficiently established as to whether or not drinking cessation subsequently reduces the
risk of liver cancer and if it does reduce the risk how long it takes for this heightened risk to fall to that of never
drinkers. This question is important for effective policy design and evaluation, to establish causality and for
motivational treatments.
Methods: A systematic review and meta-analysis using the current available evidence and a specific form of
Generalised Least Squares is performed to assess how the risk of liver cancer changes with time for former
drinkers.
Results: Four studies are found to have quantified the effect of drinking cessation on the risk of liver cancer. The
meta-analysis suggests that the risk of liver cancer does indeed fall after cessation by 6-7% a year, but there
remains a large uncertainty around this estimate both statistically and in its interpretation. As an illustration it is
estimated that a time period of 23 years is required after drinking cessation, with a correspondingly large 95%
confidence interval of 14 to 70 years, for the risk of liver cancer to be equal to that of never drinkers.
Conclusion: This is a relatively under researched area and this is reflected in the uncertainty of the findings. It is
our view that it is not possible to extrapolate the results found here to the general population. Too few studies
have addressed this question and of the studies that have, all have significant limitations. The key issue amongst
the relevant studies is that it appears that current drinkers, abstainers and former drinkers are not composed of, or
effectively adjusted to be, similar populations making inferences about risk changes impossible. This is a very
difficult area to study effectively, but it is an important topic. More work is required to reduce both statistical
uncertainty and tackle the various study limitations this paper highlights and until this is done, the current result
should be considered preliminary.
Background
Several studies in different countries have investigated
the relationship between alcohol cessation and the risk
of liver cancer that confirm the association of higher
alcohol consumption and increased risk of liver cancer
(also known as hepatocellular carcinoma)[1-3]. The Gut-
jahr et al. overview and meta-analysis[4] reports that
relative risks of liver cancer for low, hazardous and
harmful levels of alcohol consumption compared to
never drinkers are 1.45, 3.03, and 3.60 respectively
(Where low consumption = (0-19.90 grams (females), 0-
39.99 grams (males) pure alcohol per day), hazardous
consumption = (females 20-39.99 grams, males 40-59.99
grams), harmful consumption = (females 40+ grams,
males 60+ grams)). Whilst it is established that alcohol
increases the risk of liver cancer, it is not established to
what extent this increased risk is reversible through
abstention of alcohol consumption.
In addition to confirming whether or not alcohol has a
causal detrimental impact on the risk of liver cancer, it
is also interesting from a policy perspective to under-
stand which policies will best reduce the increased risk
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of liver cancer due to alcohol consumption. Evidence of
reversibility will mean effective policies with the aim of
reducing consumption will have a positive impact. If
alcohol induced risk is not reversible (in a relatively
short period of time) it will be better to focus on pre-
vention. Evidence of reversibility could also be impor-
tant for motivational treatments.
This paper forms part of a larger project investigating
the avoidable cost of alcohol. To estimate the avoidable
cost of alcohol it is necessary to understand the way in
which risk declines (or increases) post alcohol consump-
tion cessation/reduction. There exists evidence on the
impact of alcohol cessation on liver cirrhosis. Jarl et al.
2010[5] show that from the point of alcohol cessation
there is a lag of around 20 years for men and 23 years
for women for the heightened risk of liver cirrhosis to
fall to that of never drinkers. It is then calculated that
72% of the total attributable cost of alcohol caused liver
cirrhosis could potentially be avoided[5]. Similarly Rehm
et al 2007[6] investigate the temporal sequence and the
strength of the association between the risk of oesopha-
geal, head and neck cancer changes and alcohol cessa-
tion. However, there currently does not exist a summary
of the evidence of the impact of alcohol cessation on
liver cancer. It is also hoped that highlighting the ques-
tion of reversibility will spawn further research in this
area.
The purpose of this study is to assess to what extent
alcohol-related-elevated-risk of liver cancer is reversi-
ble and, if so, how many years after drinking cessation
it would take for the elevated-risk of cancer to fall
back to that of never drinkers. This paper addresses
the lack of an overview of the evidence base in this
area by performing both a systematic literature review
of the current epidemiological research and a meta-
analysis of the results from the systematic review. The
first section sets out the methodology of the systematic
review, the data extraction process and the meta-analy-
sis methodology. The meta-analysis results are then
presented. The paper concludes with a discussion of




A systematic literature search was conducted indepen-
dently by one author in June and July, 2010 to review
and summarise epidemiological studies on effects of
alcohol cessation on the risk of liver cancer (ICD 10
code C22). The results were then independently verified
by another author and updated to May 2011. Both the
PRISMA 2009 checklist and MOOSE statement 2000
checklist for preferred reporting items have been fol-
lowed. The search terms below were used.
["alcohol” AND ("liver cancer” OR “liver cell carci-
noma” OR “malignant neoplasm of liver” OR “hepatocel-
lular carcinoma” OR “malignant hepatoma” OR “liver
sarcoma” OR “hepatoblastoma” OR “hepatoma” OR
“liver angiosarcoma” OR “intrahepatic bile duct carci-
noma” OR “cholangiocarcinoma” OR “kupffer cell sar-
coma”) AND ("risk” OR “association” OR “relationship”
OR “relation” OR “correlation” OR “connection” OR
“link”) AND ("cessation” OR “quit drinking” OR “quit-
ting drinking” OR “stop drinking” OR “stopping drink-
ing” OR “abstainers” OR “abstinence” OR “ex-drinkers”
OR “former drinkers” OR “withdrawal” OR “withdraw”
OR “cease drinking” OR “give up drinking” OR “discon-
tinue drinking” OR “halt drinking”)]. Liver cancer was
again replaced with ICD 10 code C22 in another search.
The search was initially performed in PUBMED and
MEDLINE.
Selection of studies
The following exclusion criteria were applied; (1) the
study was not published in English; (2) the study was
not performed on humans; (3) the study was not
designed to capture data on alcohol cessation (ex-drin-
kers) or did not distinguish between lifetime abstainers
and former drinkers (those who had quit drinking and
those who never drank alcohol); and (4) the study did
not investigate cancer of the liver.
The search initially yielded 44 articles in PUBMED
and MEDLINE. Inspection of abstracts narrowed it
down to 15 articles potentially relevant to the current
study area. These articles were read in full and the refer-
ence lists were searched manually. Complementary
search was done in ERIC, CINAHL, Google scholar and
Google. In all, eleven relevant articles were obtained
that met the set criteria (above) to be included in the
review and are summarised and compared in Additional
file 1. This is shown schematically in a flow diagram in
Figure 1. Of the eleven relevant studies that look at the
effect of drinking cessation on the risk of liver cancer,
five capture data on the duration of cessation.
Data extraction
Five relevant studies were identified by the systematic
review that quantified the risk impact on liver cancer of
drinking cessation and the duration of drinking cessa-
tion. In two studies (Ozasa and Ogimoto et al.)[7,8] the
same data was partially used. In order not to give inap-
propriate weight to this particular dataset, only the most
recent study was included in the meta-analysis, leaving
four studies. The data is extracted in order to summar-
ise what the available evidence suggests. It should be
acknowledged that any findings must be interpreted
with caution due to the limited amount of evidence
available on this topic.
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Information extracted from selected articles includes
but is not limited to; country and study years, study
type, sample size, age, gender specific calculations, sta-
tistical methods, whether incidence of liver cancer was
confirmed by histology, definition of a former drinker
and risk estimates with confidence intervals (see Addi-
tional file 1).
Drinking cessation was presented in categories in the
studies. To convert this into a “dose” measure the mid
points of the categories were used. Where the category
was open ended the same interval width as the previous
category was used. In some studies “never drinker” was
used as the reference category in the risk estimation.
For such studies, the risk estimates were re-calculated
using “current drinker” as the reference category on the
assumption that just quitters are best matched to cur-
rent drinkers as a reference group. Standard errors and
cell numbers used to calculate the adjusted odds ratios
in the original papers were imputed using the method
set out in Hamling et al 2008[9]. Confidence intervals
(at the 95% level) were then re-calculated for the papers
where the reference group was changed to current
drinkers.
An additional dataset was also created where those
who just quit drinking are used assuming that the
observed risk at first period after cessation is equal to
Key word search performed in MEDLINE and PUBMED, complementary search 
performed in ERIC and CINAHL 
Studies included for abstract review: 
n=44 
Excluded; the study was not performed 
on humans: 
n=2 
Excluded; the study was not designed 
to capture data on alcohol cessation 
(ex-drinkers) or did not distinguish 
between lifetime abstainers and former 
drinkers and/or did not investigate 
cancer of the liver: 
n=23 
Studies read in full: 
n=15 
Studies included for review: 
n=11 
Excluded; the study did not meet the 
search criteria: 
n=8 
Included; manual search of reference 
lists from studies read in full: 
n=4 
Included; complementary search 
performed using first 30 hits of Google 
Scholar and Google: 
n=0 
Excluded; the study was not published 
in English: 
n=4 
Figure 1 Flow diagram of the selection process for the papers selected to be included in the systematic review.
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the risk at point of cessation. Again, the standard errors
and 95% confidence intervals are calculated based on
the imputed cell numbers derived from the Hamling et
al. 2008[9] approach. This additional dataset was created
because although using current drinkers as the reference
group has a clear logic and message, it is often the case
that the former drinker category has a different compo-
sition to that of current drinkers[10]. In order to deter-
mine how risk declines after alcohol cessation it is
necessary for treatment and control groups to be com-
parable to be able to make any robust conclusions. If
the two groups are different and these differences have
not been effectively controlled for then it isn’t possible
to make any robust conclusions about how the risk of
liver cancer changes after alcohol consumption.
Meta-analysis - Statistical methodology for trend
estimation
The effect measure of interest is the relative risk (RR) of
liver cancer as this is the most appropriate for the cost
of alcohol literature. However, some studies report odds
ratios (ORs) and others present hazard ratios (HRs). At
low prevalence levels it can be assumed that RR, OR
and HR are approximately equal. Due to the nature of
liver cancer and its low prevalence amongst the popula-
tion all measures will be treated as ORs. This allows for
greater mathematical ease whilst still allowing the inter-
pretation in terms of relative risks.
The problem of bias amongst published studies, in
particular the issue of publication bias, is considered
through the utilisation of funnel plots of the data, with
current drinkers as the reference group. This is a helpful
tool although other interpretations other than publica-
tion bias are not excluded. See Egger, M. et al.[11] for a
comprehensive discussion of potential sources of bias in
meta-analysis.
In traditional meta-analysis the risks are weighted by
the inverse of their variance (Weighted Least Squares)
with the assumption that the variances are independent.
However, it cannot be realistically assumed that the var-
iance of the odds ratios by duration are independent
when they are all estimated using a common reference
group within each study. Ignoring this underestimates
the variance of the slope and consequently will lead to
spurious accuracy of reported standard errors. A pro-
posed strategy to deal with this is suggested by Green-
land et al.[12] whereby only the summary estimates and
marginal data are required to get an efficient estimate.
This utilises a Generalised Least Squares (GLS)
approach using an iteratively estimated variance covar-
iance matrix to scale the estimate. The application of
the adjusted variance covariance matrix accounts for the
higher true variance in the estimates to give a more
accurate picture of the statistical uncertainty. This
approach is adopted and all dose-response information
is pooled prior to estimation.
In estimating the trend of years since cessation of
alcohol (dose) and the log risk of liver cancer, additional
explanatory variables will be utilised including a squared
term to test whether a nonlinear association between
log odds ratio of liver cancer and duration of alcohol
cessation exists as well as controls for heterogeneity
between and within studies. This approach is called the
“fixed effects meta-regression” model, which assumes
that each study is estimating the same underlying trend.
After controlling for study specific differences, the errors
are assumed to have a zero mean distributed with nor-
mal variance:
Yit = Xitβ + eit where eit ∼ N(0, σ 2i )
Where b is a k × 1 vector of coefficients and Xit is a t
× k matrix of k covariates for study i, dose period t.
When applying the fixed effects meta-regression model
using GLS on dose-response data a test for heterogene-
ity is the Q test:
Q = (Y − Zβ)′−1(Y − Xβ)
where Σ is the estimated variance covariance matrix
estimated using the method proposed by Greenland et
al. in the GLS estimate[12]. This is evaluated using the
chi-square distribution, n-k degrees of freedom (k is the
number of coefficients) with the null hypothesis that the
model is fitted correctly and there is no unexplained
between-study heterogeneity. If the null is not rejected,
due to low power, it can only be said that the statistic
could not detect any significant between-study heteroge-
neity, not that there is no heterogeneity[13].
Results
This section focuses on the results of the meta-analysis.
The results should be considered preliminary due to the
limited available evidence in this area. The results of the
systematic literature review are presented in Additional file
1. Figure 2 depicts the dose-response relationship as found
in the four studies appropriate for inclusion in the meta-
analysis. The combined total number of observations is 19
where the reference group is current drinkers and 13 where
the reference group is just quitters. All studies show an
increase in risk for recent quitters of alcohol compared to
current drinkers. There is however, a clear decline in risk
beyond the first measured point after cessation with the
exception of the findings for women (it should be noted
that both female groups are based on very small samples).
Figure 3 graphically illustrates the association between
significance of results and effect size in the included stu-
dies. It is not clear that there is any bias as the results
are in the wrong direction to what medical science
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would expect and there are equally as many non-signifi-
cant results as significant results. There is little to indi-
cate that publication bias is an issue.
Table 1 presents the results from the GLS meta-analy-
sis trend estimation regressions. Models 1-3 are applied
to the data with current drinkers as the reference group
and estimate a log linear, then a log non linear relation-
ship between time since cessation (dose) and the risk of
liver cancer. There is a clear inverse squared relation-
ship between risk of liver cancer and time, capturing the
observed higher risk of those who have just quit drink-
ing compared to current drinkers and the subsequent
fall in risk over time for the former drinker group. Indi-
vidually dummies for gender, between-study differences
(Study characteristics) and radiation (which controls for
one study performed on a population sample from
Nagasaki and Hiroshima) all show significance (results
not shown). However, the trend coefficients become
non-significant when a dummy variable is used to allow
for a structural break between the first ten years of ces-
sation and subsequent years. The regression is unable to
fit a trend when a structural break is included to
account for the higher risk of just quitters, and in many
of the studies former drinkers in general compared to
current drinkers. This implies that the only statistically
significant relationship that we observe is that former
drinkers who recently quit drinking have a higher risk
of liver cancer than current drinkers in these studies.
According to the Q statistic, accounting for the higher
risk of former drinkers in the first measured period of
cessation accounts for most of the heterogeneity
between the studies.
Models 4-6 are applied to the data where former drin-
kers who have just quit (shortest recorded cessation per-
iod) are used as the reference group and all other
former drinker categories of longer duration are com-
pared to this group. Structural heterogeneity and/or
influences on the trend estimate of risk decline of liver
cancer after drinking cessation are explored. Model 4 is
a simple regression of dose and log risk and finds a
reversible effect of drinking cessation on the risk of liver
cancer. It is not clear that there is a non-linear relation-
ship between the log odds ratio of liver cancer and
duration of alcohol cessation because including a second
polynomial makes the linear dose term non-significant
(results not shown). The second polynomial is therefore
dropped. Gender no longer has a structural impact on
the estimates which is not surprising given the very
small samples of the female estimates (again results not
shown). Only the dummy “Radiation” is significant. The
“study characteristics” dummy is tested to see if it influ-
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Note: broken line represents linearly interpolated data between two cessation periods where there is no information between these periods
Figure 2 Odds ratio for former drinkers by duration of cessation, current drinkers as reference category.
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estimates are different between study types. The results
from models 4-6 all show consistent trend estimates
and indicate no measureable between study heterogene-
ity as per the Q statistic suggesting this is a robust rela-
tionship and a common trend exists between the
studies.
Sensitivity analysis
Testing the importance of how dose is coded
Table 2 shows the results from some sensitivity analyses
assessing whether or not the results presented here are
sensitive to how dose is coded for the meta-analysis
regression. Both models 3 and 6 are re-runs using the
0
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Figure 3 An assessment for publication bias - the funnel plot test.
Table 1 Meta-analysis results: Change in odds ratio of liver cancer after an additional year not drinking
Compared to current drinkers Compared to just quitters
Model 1 2 3 4 5 6
Dose (A year of not drinking) 1.08 1.40 1.07 0.94 0.93 0.93
Dose squared 0.98 1.00
Controls for:
Study characteristics* No No No No Yes Yes
Radiation fall out No No No No No Yes
Quit in last ten years No No Yes No No No
Dose*Study characteristics No No No No No Yes
Q statistic # 144.3 55.8 15.9 19.0 18.1 6.6
*Study characteristics = 1 if the study was in Japan, a prospective cohort design, had no minimum gap between giving up drinking and joining study, and no
controls for hepatitis. # pr>Chi2 that there is no heterogeneity according to the Q statistic. Bold represents statistically significant figures at the 95% confidence
level, or Q statistic finds no heterogeneity
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lowest value from each dose category rather than the
middle value. The results do not differ substantially
given quite a dramatic difference in how dose is coded.
This suggests that the original estimates found from
Models 3 and 6 are quite robust relationships and not
sensitive to coding options.
Discussion
Across all of the studies two types of study design were
used, either case-control or prospective cohort. All of
the eleven studies found in the systematic review show
that the risk of liver cancer just after alcohol cessation is
either the same or higher compared to current drinkers.
Given the detrimental effect of alcohol, an a priori
expectation was that the risk would be lower after cessa-
tion, all else equal.
Due to the nature of case-control and prospective
cohort studies, matching of treatment and control
groups and/or controlling for confounding factors such
as smoking, diabetes and past drinking habits (and other
factors known to have an influence on risk of liver can-
cer) are important to ensure the effect of alcohol cessa-
tion is being isolated. Indeed some of the studies
presented in the systematic review show that smoking
matters and that there is an interaction effect between
smoking and alcohol consumption[14], but no study
looks to control for both duration of alcohol cessation
and smoking habits. The amount of alcohol consumed
prior to cessation is expected to influence the risk of
liver cancer too[4], yet none of the studies presented
here control for this when comparing treatment and
control groups. Diabetes is also commonly looked at but
rarely at the same time as the effect of cessation of alco-
hol consumption on the risk of liver cancer.
However, beyond showing that various factors increase
the risk, none of the studies presented here control for
all of them when considering the time effect of alcohol
cessation on liver cancer. It is therefore not clear that
these studies are able to isolate the average treatment
effect of alcohol cessation on the risk of liver cancer.
The design of the studies and the lack of effective con-
trols for confounding factors (possibly as a consequence
of lack of focus on the question at hand) are likely to
bias the end results. It means that the reader cannot be
sure whether there is a real relationship between the
observed risk of treatment and control groups or
whether this is due to some other unobserved or uncon-
trolled for factors.
The problem is particularly acute here where the med-
ical assumption of reversibility would predict a lower
risk of cancer post cessation of alcohol compared to
current drinkers if both groups being compared are
representative of the population, yet what is observed is
that just quitters have a higher risk of liver cancer than
current drinkers. Prior studies have found that “former
drinker” categories are often over-represented by former
heavy drinkers and alcoholics[10]. If this is the case,
then the risk of liver cancer for the cessation group
before cessation would be higher than for the general
group of current drinkers, and the increase in risk after
cessation is an artefact of poorly matched groups. This
is something that could have been controlled for but
none of the studies presented any information on this.
There are also reasons to doubt that for some of the
studies the choice of control group is a reasonable
representation of the population. Some of the studies
removed certain individuals from the control groups
who had past history of liver disease or certain illnesses
making the risk of liver cancer in the control groups
artificially low (see appendix 1 for details). There is not
enough information about the control and treatment
groups to test whether there are any important systema-
tic differences between them that may explain why an
increase in risk is observed for just quitters compared to
current drinkers but serious doubts remain about how
well they have been matched. There is also not enough
information to assess how well either the control or
treatment groups represent the wider population to be
able to make an assessment of the external validity of
the results. This implies that the results of the included
Table 2 Sensitivity analysis of meta-analysis to the coding of years since cessation
Model: 3 (original results) 3 (New dose coding) 6 (original results) 6 (New dose coding)
Dose (1 year of not drinking) 1.07 1.00 0.93 0.92
Dose squared 1.00 1.00
Controls for:
Study characteristics* No No Yes Yes
Radiation No No Yes Yes
Quit in last ten years Yes Yes No No
years since cessation*heterogeneity No No Yes Yes
Q statistic # 15.9 18.38 6.6 7.95
* Study characteristics = 1 if the study was in Japan, a prospective cohort design, had no minimum gap between giving up drinking and joining study, and no
controls for hepatitis. # pr>Chi2 that there is no heterogeneity according to the Q statistic. Bold represents statistically significant figures at the 95% confidence
level, or Q statistic finds no heterogeneity
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studies and thus also this meta-analysis have a limited
interpretation to that of the studied samples. The wider
implications for the general population are debatable.
In order to account for this uncertainty and summar-
ise the current position of the literature, a preliminary
meta-analysis has been performed on two different
forms of the same data to assess if there was any corre-
spondence between the studies on the shape of the
dose-response relationship of alcohol cessation and liver
cancer. The first uses current drinkers as the reference
category and calculates the dose-response relationship
assuming current drinkers are the relevant reference
group. The second deals with the potential overrepre-
sentation of former heavy drinkers in the cessation
group and uses just quit drinking as the reference cate-
gory. Although this has the downside of reducing the
sample size, it was expected to allow for a more accu-
rate calculation of how risk declines after cessation of
alcohol consumption.
The results where current drinkers were used as the
reference group found only that recent quitters have
much higher risk of liver cancer than current drin-
kers. Using former drinkers who had just quit as the
reference group found a statistically significant down-
ward trend in risk of liver cancer over time post ces-
sation. This is the preferred estimate as it appears
that it is based on a much better match between
treatment and control groups. To answer the question
at hand it is paramount that both treatment and con-
trol groups are representative of each other. If they
differ in a significant way that biases the results it is
impossible to draw robust conclusions about how risk
changes after cessation of alcohol consumption. It
seems that former drinkers in these studies have
worse health than current drinkers and given that all
of the former drinkers in these studies were at one
time “just quitters” it then appears more sensible to
use just quitters as the preferred control group. The
rate of risk decline using just quitters as the reference
group is quite robust to specification and common
across the studies.
By way of illustration, the findings from the meta-ana-
lysis tentatively suggest that for each year of cessation
the risk of liver cancer declines by about 6-7% i.e. there
is exponential decay. In order to calculate the length of
time until increased risk of liver cancer has fallen to
that of never drinkers, the relative risk of former drin-
kers compared to never drinkers is required. To ensure
internal consistency of the estimates (acknowledging
that a more precise and externally valid estimate is
probably available in the literature), supplementary
meta-analysis, not shown here, finds that the average
odds ratio between just quit drinking and never drinkers
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Figure 4 Illustration: Risk decline of liver cancer post cessation of alcohol consumption compared to just quitters.
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from model 6 to illustrate what the current evidence
suggests, it is estimated that it would take about 23
years (with correspondingly large 95% confidence inter-
val of 14-70 years i.e. a confidence interval spanning 56
years) for the risk of liver cancer of quitters of alcohol
to fall to that of never drinkers. This illustrative example
based on the meta-analysis is shown diagrammatically in
Figure 4.
Conclusions
The rate of risk decline estimated here has great statis-
tical uncertainty. It is also difficult to interpret, as the
interpretation depends on whether the trend is the
same for all groups or varies by key factors e.g. smok-
ing, past alcohol consumption patterns, gender and
age. The current extent of the literature means it is
not known if this trend does vary by these key factors.
It appears that the trend estimate found here is for a
subgroup of the population but it is not possible to say
what this sub-population looks like. There is indicative
evidence that the treatment groups appear to be dis-
similar to current drinkers and exhibit the patterns
observed in heavy drinkers. Due to these issues, the
results presented here should be interpreted with
caution.
Many questions remain and more research is needed
in this important area. Future research looking into the
cessation effect of alcohol consumption on liver cancer
will need to consider more seriously how well matched
their treatment and control groups are, especially with
regard to behaviours and factors associated with liver
cancer outcomes. Care also needs to be taken in allow-
ing interpretation of the external validity of the findings,
either by controlling for characteristics so that broader
conclusions can be drawn or by using sampling in a way
that more accurately represents the wider population.
The question at hand here also requires a long follow
up as it is indicated in this study that the rate of decay
in risk occurs over a substantial time period.
Given the difficult nature of studying alcohol intake’s
effect on human outcomes and the difficulty of separat-
ing the choice from the chooser, an effective study may
need to make use of a policy experiment rather than
just observe people’s behaviour. The policy would have
to be aimed at reducing intake of alcohol. An experi-
ment large enough with a well matched and representa-
tive control group, ideally chosen at random would
present both the ability to effectively assess the effective-
ness of the policy and the effect of reduced alcohol
intake on various outcomes (if the policy was effective
of course).
Additional material
Additional file 1: Detailed findings from the systematic review. A
descriptive overview of the current literature examining the effect of
alcohol cessation on liver cancer, including the raw data used in the
meta-analysis.
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